-+ 0.00%
-+ 0.00%
-+ 0.00%

ADC Therapeutics Q1 Adj. EPS $(0.22) Beats $(0.40) Estimate, Sales $23.03M Beat $17.71M Estimate

Benzinga·05/14/2025 12:04:24
Listen to the news
ADC Therapeutics (NYSE:ADCT) reported quarterly losses of $(0.22) per share which beat the analyst consensus estimate of $(0.40) by 45 percent. This is a 42.11 percent increase over losses of $(0.38) per share from the same period last year. The company reported quarterly sales of $23.03 million which beat the analyst consensus estimate of $17.71 million by 30.05 percent. This is a 27.57 percent increase over sales of $18.05 million the same period last year.